Compare Abbott Laboratories (ABT) vs Spotify Technology (SPOT) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs Spotify Technology — how do they compare? Abbott Laboratories trades at $95.4 (market cap $166.94B), while Spotify Technology trades at $486.15 (market cap $101.57B). The key difference: Abbott Laboratories is the larger of the two by market cap, and Abbott Laboratories pays a 2.63% dividend while Spotify Technology pays none. Which is the better fit depends on your goals.
| ABT | SPOT | |
|---|---|---|
Market Cap | $166.94B | $101.57B |
Sector | Health | Media |
52-Week High | $136.62 | $738.53 |
52-Week Low | $82.57 | $412.75 |
Enterprise Value | $193.69B | $92.15B |
Dividend Yield | 2.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
Spotify (SPOT) trades at $493.95, up 1.64% with a bullish technical outlook. The stock shows strong fundamentals with revenue growth from $11.7B in 2022 to $17.2B in 2025 and net income turning positive to $2.2B. Analyst consensus is bullish with a $623 price target, supported by recent earnings beats. Key resistance is near $499, while support holds at $477.
Outlook remains positive driven by margin expansion and platform diversification, but risks include competition and market volatility. The stock offers growth potential with a 26% upside to consensus target, though investors should monitor execution on profitability goals amid rising content costs.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About Spotify Technology
Spotify Technology S.A. provides music streaming services. The Company offers commercial-free music and ad-supported services to subscribers. Spotify Technology serves clients worldwide.
Read more on SPOT →
